Thrombin time is prolonged by:
Thrombin inhibitors, such as unfractionated heparin, low molecular weight heparin (eg. Enoxaparin [Lovenox]), Lepirudin (Refludin), Argatroban, and Dabigatran (Pradaxa)
Fibrinogen quantitative abnormality
Fibrinogen qualitative abnormality (dysfibrinogenemia)
Inhibitors of fibrin monomer polymerization (ie. fibrinogen degredation products and/or some paraproteins)